RAFAEL HOLDINGS, INC. Common Stock, Convertible, Conversion Price, Decrease
RAFAEL HOLDINGS, INC. (RFL) reported Common Stock, Convertible, Conversion Price, Decrease of $0.97 per share for the 6-month period ending 2024-01-31, per its 10-Q filed 2024-03-14.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockConvertibleConversionPriceDecrease · last filed 2024-03-14
- 2024-01-31: Common Stock, Convertible, Conversion Price, Decrease 6 month $0.97.
| Period end | Common Stock, Convertible, Conversion Price, Decrease 6 month |
|---|---|
| 2024-01-31 | $0.97 10-Q · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |